Harpoon Therapeutics, Inc. (HARP): Price and Financial Metrics


Harpoon Therapeutics, Inc. (HARP): $1.18

0.24 (+25.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HARP to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

HARP Stock Price Chart Interactive Chart >

Price chart for HARP

HARP Price/Volume Stats

Current price $1.18 52-week high $6.20
Prev. close $0.94 52-week low $0.59
Day low $0.97 Volume 2,232,472
Day high $1.19 Avg. volume 610,656
50-day MA $0.79 Dividend yield N/A
200-day MA $1.58 Market Cap 39.07M

Harpoon Therapeutics, Inc. (HARP) Company Bio


Harpoon Therapeutics, Inc. develops antibody therapies to treat cancer patients. It develops a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets. The company founded by Patrick A. Baeuerle and Luke B. Evnin in 2015 and is headquartered in South San Francisco, CA.


HARP Latest News Stream


Event/Time News Detail
Loading, please wait...

HARP Latest Social Stream


Loading social stream, please wait...

View Full HARP Social Stream

Latest HARP News From Around the Web

Below are the latest news stories about HARPOON THERAPEUTICS INC that investors may wish to consider to help them evaluate HARP as an investment opportunity.

Stocks Hold Gains Ahead Of Tuesday's Economic Flurry

The major indexes are continuing their move higher this afternoon, as investors await tomorrow's release of November's consumer price index (CPI) data.

TalkMarkets.com | December 12, 2022

Read More 'HARP' Stories Here

HARP Price Returns

1-mo 97.65%
3-mo 25.64%
6-mo -39.49%
1-year -76.06%
3-year -91.92%
5-year N/A
YTD 62.60%
2022 -90.39%
2021 -54.55%
2020 12.31%
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5931 seconds.